Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | SRC | P12931 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | CA4 | P22748 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21652595 | 0.89 | SRD5A2 (0.56) | ALDH1A1KMT2AGAATDP1ALOX15 | |
| SCHEMBL12979661 | 0.88 | SRC (0.46) | ALDH1A1KMT2AGAATDP1ALOX15 | |
| SCHEMBL30251446 | 0.87 | ALDH1A1 (0.47) | ALDH1A1KMT2AGAATDP1ALOX15 | |
| SCHEMBL28199599 | 0.87 | ALDH1A1 (0.51) | ALDH1A1KMT2AGAATDP1ALOX15 | |
| SCHEMBL4192923 | 0.84 | BCAT2 (0.46) | ALDH1A1KMT2AGAATDP1MAPT | |
| SCHEMBL11603922 | 0.83 | ALDH1A1 (0.55) | ALDH1A1KMT2AGAATDP1ALOX15 | |
| SCHEMBL28193779 | 0.83 | ALDH1A1 (0.44) | ALDH1A1KMT2AGAATDP1ALOX15 | |
| SCHEMBL9580764 | 0.82 | LMNA (0.55) | ALDH1A1KMT2AGAATDP1ALOX15 | |
| SCHEMBL27543079 | 0.82 | AKR1C3 (0.52) | ALDH1A1KMT2AGAATDP1MAPT | |
| SCHEMBL11602789 | 0.82 | ALDH1A1 (0.62) | ALDH1A1KMT2AGAATDP1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120154564-A | Preparation method of stable veterinary oral paste composition | 北京欧博方医药科技有限公司 | 2025-06-17 | — | — | CN | claimed |
| CN-118632933-A | Screening method for substance inhibiting odor of 4-methylacetophenone and method for inhibiting odor of 4-methylacetophenone | 味之素株式会社 | 2024-09-10 | — | — | CN | disclosed |
| CN-118591301-A | Method for inhibiting odor of p-cresol | 味之素株式会社 | 2024-09-03 | — | — | CN | disclosed |
| CN-117396490-A | Bicyclic heterocyclic compounds for the prevention and treatment of viral infections | BM医药咨询有限公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-116332809-A | Process for producing alkylamine derivative and intermediate for production thereof | 味之素株式会社 | 2023-06-27 | — | — | CN | disclosed |
| CN-115536556-A | Process for producing alkylamine derivative and intermediate for producing the same | 味之素株式会社 | 2022-12-30 | — | — | CN | disclosed |
| CN-108699580-B | Heparan sulphate with a high 3-O-sulphation ratio in the glucosamine residue | 味之素株式会社 | 2022-09-23 | — | — | CN | disclosed |
| CN-114657079-A | Yeast with high content of Abu, gamma-Glu-Abu and/or gamma-Glu-Abu-Gly | 味之素株式会社 | 2022-06-24 | — | — | CN | disclosed |
| CN-113473977-A | Cannabidiol and/or derivatives thereof for use in the treatment of mitochondrial diseases | 巴塞罗那自治大学 | 2021-10-01 | — | — | CN | disclosed |
| EP-3134443-B1 | LED PHOTOINITIATORS | SUN CHEMICAL CORP (US) | 2019-10-30 | — | — | EP | disclosed |
| EP-3416647-A2 | N3-SUBSTITUTED IMINOPYRIMIDINONES AS ANTIMALARIAL AGENTS | Merck Sharp & Dohme Corp. (US) | 2018-12-26 | — | — | EP | disclosed |
| WO-2017142825-A2 | N3-SUBSTITUTED IMINOPYRIMIDINONES AS ANTIMALARIAL AGENTS | MERCK SHARP & DOHME CORP. (US) | 2017-08-24 | — | — | WO | disclosed |
| CN-102781354-B | To high speed Rotational atherectomy system, the apparatus and method of biological duct topical application therapeutic agent | CARDIOVASCULAR SYSTEMS, INC. (US) | 2016-03-30 | — | — | CN | disclosed |
| CN-102762168-B | Therapeutic agent delivery system for topical application of therapeutic substances to biological conduits | CARDIOVASCULAR SYSTEMS, INC. (US) | 2015-08-26 | — | — | CN | disclosed |
| CN-102917655-B | Therapeutic agent delivery system, device and method for localized application of therapeutic substances to a biological conduit | CARDIVASCULAR SYSTEMS | 2015-07-08 | — | — | CN | disclosed |
| US-20100298296-A1 | Oligomer-Tricyclic Conjugates | NEKTAR THERAPEUTICS (US) | 2010-11-25 | — | — | US | disclosed |
| WO-2009073154-A1 | OLIGOMER-TRICYCLIC CONJUGATES | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2009-06-11 | — | — | WO | disclosed |
| EP-1869269-A4 | ANTI-CASTER SURFACE LAMINATE | LG CHEMICAL LTD (KR) | 2008-05-21 | — | — | EP | disclosed |
| EP-1869269-A1 | ANTI-CASTER SURFACE LAMINATE | LG Chemical Co. Ltd (KR) | 2007-12-26 | — | — | EP | disclosed |
| WO-2006109914-A1 | ANTI-CASTER SURFACE LAMINATE | LG CHEM, LTD. (KR) | 2006-10-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298296-A1 | Oligomer-Tricyclic Conjugates | ABCG2, SLCO1B3, SLC43A1 | ALDH1A1 2609/4885KMT2A 3267/4885GAA 917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.